Deep Track Capital, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.82 Billion distributed in 66 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Immunovant, Inc. with a value of $261M, Guardant Health, Inc. with a value of $221M, Ionis Pharmaceuticals Inc with a value of $193M, Protagonist Therapeutics, Inc with a value of $179M, and Dynavax Technologies Corp with a value of $176M.

Examining the 13F form we can see an decrease of $41.4M in the current position value, from $2.86B to 2.82B.

Deep Track Capital, LP is based out at Greenwich, CT

Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $2.82 Billion
Healthcare: $2.82 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 66
  • Current Value $2.82 Billion
  • Prior Value $2.86 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 7 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.